FINWIRES · TerminalLIVE
FINWIRES

美国银行称,受经济不确定性影响,PVH、Lululemon等零售商的前景不明朗。

By

-- 美国银行证券周六在一份报告中指出,PVH集团(PVH)、Lululemon(LULU)以及其他专业零售和百货公司在持续的经济压力和关税不确定性下,近期业绩的可见性有限。 分析师表示,Lululemon宣布任命耐克(NKE)资深高管海蒂·奥尼尔(Heidi O'Neill)为新任首席执行官,将于9月8日上任。消息公布后,Lululemon股价下跌13%。尽管奥尼尔拥有来自全球知名品牌的丰富经验,但由于上任日期推迟,任何重大产品调整可能要到2027年底甚至2028年才会显现。 美国银行表示:“目前市盈率接近历史低位,但我们对新领导层下的盈利能力缺乏了解,因此维持中性评级。” PVH集团股价在4月份大幅上涨,涨幅达37%,远超大盘表现。该公司2026年的展望包括毛利率高于预期,但其在欧洲市场仍面临挑战,并依赖股票回购来提升每股收益。分析师表示,PVH集团旗下Calvin Klein品牌因一部热门电视剧而提升了知名度,但由于PVH集团在欧洲的业务占比高达50%,且该地区宏观经济面临挑战,因此仍存在一些担忧。 分析师补充道,自2月底高额关税暂停实施以来,关税一直维持在10%左右的低位。较低的关税可能会略微提高利润率,但由于3月份进口的商品要到第二季度才能售出,因此这一利好将有所延迟。预计对第一季度业绩的影响甚微。 美国银行对Lululemon的评级为“中性”,目标价为175美元。PVH的评级同样为“中性”,目标价从87美元上调至103美元。

Price: $91.88, Change: $-1.77, Percent Change: -1.88%

Related Articles

Insider Trading

Lifestance Health Group Insider Sold Shares Worth $492,400, According to a Recent SEC Filing

Robert Bessler, Director, on April 23, 2026, sold 69,899 shares in Lifestance Health Group (LFST) for $492,400. Following the Form 4 filing with the SEC, Bessler has control over a total of 1,485,228 common shares of the company, with 57,619 shares held directly and 1,427,609 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1845257/000119312526182153/xslF345X05/ownership.xml

$LFST
Australia

Celestica Q1 Adjusted Earnings, Revenue Rise; Q2 Guidance Set

Celestica (CLS) reported Q1 adjusted earnings late Monday of $2.16 per diluted share, up from $1.20 a year earlier.Analysts polled by FactSet expected $2.07.Revenue for the three months ended March 31 was $4.05 billion, up from $2.65 billion a year earlier.Analysts surveyed by FactSet expected $4.04 billion.For Q2, the company expects adjusted EPS of $2.14 to $2.34 on revenue of $4.15 billion to $4.45 billion. Analysts expect EPS of $2.13 on revenue of $4.17 billion.The company now expects 2026 adjusted EPS of $10.15 on revenue of $19 billion, revised from $8.75 and $17 billion, respectively, expected earlier. Analysts expect EPS of $8.93 on revenue of $17.34 billion.

$CLS
Research

Research Alert: CFRA Keeps Buy Opinion On Shares Of Ameriprise Financial, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We keep our 12-month target price of $550, valuing AMP shares at 12.5x our 2026 adjusted EPS estimate of $43.84 (raised by $1.34) and at 11.7x our 2027 EPS estimate of $46.90 (raised by $0.70). This compares to the three-year average forward multiple of 12x and peer average of 15.5x. AMP posted Q1 2026 adjusted operating EPS of $11.26 vs. $9.50, a 19% rise that topped our $10.12 estimate and $10.21 consensus view. Revenue growth of 11% exceeded our forecast and our 6%-10% growth forecast for 2026, while pretax adjusted operating margins expanded 130 bps to 28% on revenue gains and cost containment efforts. We now see revenue growth of 7% to 12% in 2026 and 2027. AMP also continued its substantial capital return program, returning $936M to shareholders in Q1 (70% of adjusted operating earnings) and $3.4B in 2025 (88% of earnings). Currently trading at 10.9x our 2026 EPS estimate, and with some decent revenue and earnings momentum, we view the shares as undervalued versus peer and historical averages.

$AMP